MEDP Relative Valuation
MEDP's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, MEDP is overvalued; if below, it's undervalued.
Historical Valuation
Medpace Holdings Inc (MEDP) is now in the Overvalued zone, suggesting that its current forward PE ratio of 35.08 is considered Overvalued compared with the five-year average of 30.12. The fair price of Medpace Holdings Inc (MEDP) is between 389.59 to 527.45 according to relative valuation methord. Compared to the current price of 549.58 USD , Medpace Holdings Inc is Overvalued By 4.2%.
Relative Value
Fair Zone
389.59-527.45
Current Price：549.58
4.2%
Overvalued
33.15
PE
1Y
3Y
5Y
Trailing
Forward
27.16
EV/EBITDA
Medpace Holdings Inc. (MEDP) has a current EV/EBITDA of 27.16. The 5-year average EV/EBITDA is 22.44. The thresholds are as follows: Strongly Undervalued below 14.75, Undervalued between 14.75 and 18.60, Fairly Valued between 26.29 and 18.60, Overvalued between 26.29 and 30.14, and Strongly Overvalued above 30.14. The current Forward EV/EBITDA of 27.16 falls within the Overvalued range.
28.59
EV/EBIT
Medpace Holdings Inc. (MEDP) has a current EV/EBIT of 28.59. The 5-year average EV/EBIT is 24.38. The thresholds are as follows: Strongly Undervalued below 15.79, Undervalued between 15.79 and 20.08, Fairly Valued between 28.68 and 20.08, Overvalued between 28.68 and 32.97, and Strongly Overvalued above 32.97. The current Forward EV/EBIT of 28.59 falls within the Historic Trend Line -Fairly Valued range.
5.86
PS
Medpace Holdings Inc. (MEDP) has a current PS of 5.86. The 5-year average PS is 4.49. The thresholds are as follows: Strongly Undervalued below 2.82, Undervalued between 2.82 and 3.66, Fairly Valued between 5.33 and 3.66, Overvalued between 5.33 and 6.16, and Strongly Overvalued above 6.16. The current Forward PS of 5.86 falls within the Overvalued range.
23.24
P/OCF
Medpace Holdings Inc. (MEDP) has a current P/OCF of 23.24. The 5-year average P/OCF is 21.47. The thresholds are as follows: Strongly Undervalued below 13.67, Undervalued between 13.67 and 17.57, Fairly Valued between 25.37 and 17.57, Overvalued between 25.37 and 29.27, and Strongly Overvalued above 29.27. The current Forward P/OCF of 23.24 falls within the Historic Trend Line -Fairly Valued range.
25.44
P/FCF
Medpace Holdings Inc. (MEDP) has a current P/FCF of 25.44. The 5-year average P/FCF is 24.42. The thresholds are as follows: Strongly Undervalued below 14.32, Undervalued between 14.32 and 19.37, Fairly Valued between 29.48 and 19.37, Overvalued between 29.48 and 34.53, and Strongly Overvalued above 34.53. The current Forward P/FCF of 25.44 falls within the Historic Trend Line -Fairly Valued range.
Medpace Holdings Inc (MEDP) has a current Price-to-Book (P/B) ratio of 56.15. Compared to its 3-year average P/B ratio of 23.12 , the current P/B ratio is approximately 142.86% higher. Relative to its 5-year average P/B ratio of 17.62, the current P/B ratio is about 218.59% higher. Medpace Holdings Inc (MEDP) has a Forward Free Cash Flow (FCF) yield of approximately 0.00%. Compared to its 3-year average FCF yield of 4.88%, the current FCF yield is approximately -100.00% lower. Relative to its 5-year average FCF yield of 4.62% , the current FCF yield is about -100.00% lower.
53.06
P/B
Median3y
23.12
Median5y
17.62
4.17
FCF Yield
Median3y
4.88
Median5y
4.62
Competitors Valuation Multiple
The average P/S ratio for MEDP's competitors is , providing a benchmark for relative valuation. Medpace Holdings Inc Corp (MEDP) exhibits a P/S ratio of , which is NaN% above the industry average. Given its robust revenue growth of 23.74%, this premium appears sustainable.
P/S
P/E
EV/EBITDA
EV/EBIT
P/S
Revenue Growth
Market Cap
Performance Decomposition
1Y
3Y
5Y
Market capitalization of MEDP increased by 63.97% over the past 1 year. The primary factor behind the change was an increase in P/E Change from 25.86 to 38.04.
The secondary factor is the Revenue Growth, contributed 23.74%to the performance.
Overall, the performance of MEDP in the past 1 year is driven by P/E Change. Which is more unsustainable.
People Also Watch
FAQ
Is Medpace Holdings Inc (MEDP) currently overvalued or undervalued?
What is Medpace Holdings Inc (MEDP) fair value?
How does MEDP's valuation metrics compare to the industry average?
What is the current P/B ratio for Medpace Holdings Inc (MEDP) as of Dec 05 2025?
What is the current FCF Yield for Medpace Holdings Inc (MEDP) as of Dec 05 2025?
What is the current Forward P/E ratio for Medpace Holdings Inc (MEDP) as of Dec 05 2025?